Category: flu
Cue Health raises $100 million to speed development of rapid, portable COVID-19 diagnostics
San Diego-based startup Cue Health has closed a $100 million Series C funding round, including participation from Decheng Capital, Foresite Capital, Madrone Capital Partners, Johnson & Johnson Innovation, ACME Capital and others. The funding will be used to help Cue finish up development, validate and scale production of its Cue…
Read More
New coronavirus research suggests vaccines developed to treat it could be long-lasting
A new study from Italian researchers suggests that the SARS-CoV-2 coronavirus, which is the cause of the COVID-19 pandemic currently causing a global health crisis, is relatively slow to mutate – meaning that any effective vaccine that is developed to prevent people from getting infected should be broadly effective across…
Read More
Amazon Care to provide delivery and pick-up of at-home COVID-19 test sample kits in Seattle trial
Amazon is going to be working with a new research initiative backed in part by the Gates Foundation that will distribute at-home coronavirus assessment kits, and then deliver the collected samples to FDA-approved test facilities. Amazon Care, the health arm formed by Amazon initially for internal employee care, will be…
Read More
A new type of COVID-19 test now approved for use could help with frontline diagnostics
The U.S. Food and Drug Administration (FDA) is moving much more quickly to grant special ’emergency use authorization’ to equipment and tests that could help increase testing for the novel coronavirus in the U.S., which lags behind most countries in the world when it comes to tests conducted relative to…
Read More
FluSense system tracks sickness trends by autonomously monitoring public spaces
One of the obstacles to accurately estimating the prevalence of sickness in the general population is that most of our data comes from hospitals, not the 99.9 percent of the world that isn’t hospitals. FluSense is an autonomous, privacy-respecting system that counts the people and coughs in public spaces to…
Read More
Japanese flu drug appears ‘effective’ in coronavirus treatment in Chinese clinical trials
Japanese-made flu drug favipiravir (also known as Avigan) has been shown to be effective in both reducing the duration of the COVID-19 virus in patients, and to have improved the lung conditions of those who received treatment with the drug, based on results of clinical trials conducted with affected patients…
Read More